This paper characterizes the effects of the rare APOC3 loss of function mutation on lipid metabolism in two large European population cohorts.

The results improve understanding of the role of APOC3 in triglyceride metabolism, its LPL independent action and elucidates the suitable as a new lipid-lowering target.